CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,697,582 | -4.1% | 57,623 | +6.2% | 0.00% | 0.0% |
| Q2 2023 | $1,770,118 | -46.1% | 54,265 | -41.9% | 0.00% | -50.0% |
| Q1 2023 | $3,286,149 | +134.2% | 93,383 | +204.9% | 0.01% | +100.0% |
| Q4 2022 | $1,403,234 | -74.6% | 30,625 | -73.1% | 0.00% | -75.0% |
| Q3 2022 | $5,518,000 | +35.3% | 113,881 | +9.7% | 0.01% | +33.3% |
| Q2 2022 | $4,078,000 | +59.5% | 103,769 | +49.4% | 0.01% | +80.0% |
| Q1 2022 | $2,556,000 | -24.7% | 69,440 | -6.6% | 0.01% | -16.7% |
| Q4 2021 | $3,393,000 | +24.1% | 74,335 | -2.8% | 0.01% | 0.0% |
| Q3 2021 | $2,733,000 | +360.9% | 76,471 | +151.4% | 0.01% | +500.0% |
| Q2 2021 | $593,000 | -14.6% | 30,417 | +1.9% | 0.00% | -50.0% |
| Q1 2021 | $694,000 | +0.4% | 29,843 | -10.3% | 0.00% | 0.0% |
| Q4 2020 | $691,000 | +37.4% | 33,275 | +56.0% | 0.00% | 0.0% |
| Q2 2020 | $503,000 | – | 21,326 | +152228.6% | 0.00% | – |
| Q4 2017 | $0 | – | 14 | -39.1% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 23 | -78.9% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 109 | +36.2% | 0.00% | – |
| Q3 2015 | $1,000 | – | 80 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |